These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 10597402)
1. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Koshiba T; Hosotani R; Miyamoto Y; Wada M; Lee JU; Fujimoto K; Tsuji S; Nakajima S; Doi R; Imamura M Int J Pancreatol; 1999 Oct; 26(2):69-76. PubMed ID: 10597402 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas. Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Kokawa A; Kondo H; Gotoda T; Ono H; Saito D; Nakadaira S; Kosuge T; Yoshida S Cancer; 2001 Jan; 91(2):333-8. PubMed ID: 11180079 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949 [TBL] [Abstract][Full Text] [Related]
6. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860 [TBL] [Abstract][Full Text] [Related]
7. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Maitra A; Ashfaq R; Gunn CR; Rahman A; Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Wilentz RE Am J Clin Pathol; 2002 Aug; 118(2):194-201. PubMed ID: 12162677 [TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Lüttges J; Zamboni G; Longnecker D; Klöppel G Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer. Franco L; Doria D; Bertazzoni E; Benini A; Bassi C Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):51-8. PubMed ID: 15165031 [TBL] [Abstract][Full Text] [Related]
12. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670 [TBL] [Abstract][Full Text] [Related]
13. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194 [TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas]. Wang HX; Chen QK Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas. Sawai H; Okada Y; Funahashi H; Matsuo Y; Tanaka M; Manabe T Scand J Gastroenterol; 2004 Nov; 39(11):1159-65. PubMed ID: 15545177 [TBL] [Abstract][Full Text] [Related]
16. Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. Tsutsumi K; Sato N; Cui L; Mizumoto K; Sadakari Y; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Tanaka M Mod Pathol; 2011 Apr; 24(4):533-41. PubMed ID: 21102412 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920 [TBL] [Abstract][Full Text] [Related]
18. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441 [TBL] [Abstract][Full Text] [Related]
19. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Miyamoto Y; Hosotani R; Wada M; Lee JU; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Doi R; Kato M; Shimada Y; Imamura M Oncology; 1999; 56(1):73-82. PubMed ID: 9885381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]